Calendar

Earnings news is constructive, but the stock's October 21 close of $166.91 was only about 0.9% above its $165.44 pre-print close, a restrained initial reaction to the beat. That price comparison does not establish why shares moved. Verified post-print analyst revisions are unavailable at this early T+1 checkpoint; social, options, short-interest and employee-sentiment measures were not supplied and the zero fields above denote unavailable data, not measured neutral readings. [historical prices](https://fwnbc.marketminute.com/quote/NQ%3ANTRS/historical)

The October 21 earnings release presents strong balance-sheet growth but an externally reported EPS and revenue miss. The supplied $102.78 anchor and available quote do not establish a post-release regular-session reaction. Verified post-print analyst revisions and target changes are unavailable; their absence is not positive evidence. The stored earnings-document row concerns PNFP, not SSB, and was excluded.

Initial coverage is mixed: reported adjusted EPS was above a pre-release estimate, but year-over-year profit and revenue declined. [Immediate post-release coverage](https://finance.yahoo.com/healthcare/articles/molina-healthcare-nyse-moh-q3-204800968.html) reported an approximately 4.1% after-hours decline; that is not a confirmed full-session reaction. Post-print analyst revisions were unavailable, and the earnings call had not yet been incorporated. Zeroes in unavailable sentiment fields are placeholders, not measured neutral readings.

The tone improved after the Q3 beat and guidance increase. The October 21 anchor of $233.86 is about 4.3% above the $224.24 prior close cited in contemporaneous coverage, consistent with a positive regular-session reaction despite conflicting premarket reporting. [Market reaction](https://finance.yahoo.com/markets/stocks/articles/danaher-jumps-4-q3-beat-161601362.html) The early T+1 evidence supports a positive thesis change, but no verified post-print analyst revision wave or sufficient social coverage is available. Sentiment fields other than headline buzz are unverified placeholders, not measured signals.

The October 19 close of $10.56 was about 3.4% below the October 16 close; a separate price-history source shows a rebound to $11.05 by October 21, so the initial selloff did not persist on that series. These vendor closes differ from the packet's $10.88 adjusted-close anchor, which is retained for valuation. [Price history](https://chartexchange.com/symbol/nyse-dx/historical) The reported JonesTrading target cut is a negative revision signal, but broader post-print estimate changes and a reliable consensus surprise were unavailable. The packet's earnings-document row is an Insider Monkey article, not a company release. This is a cautious T+3 monitoring view rather than evidence of a durable recovery.

The August company update is constructive, but the [Q2 earnings exhibit](https://www.sec.gov/Archives/edgar/data/1962481/000149315226037745/ex99-1.htm) precedes this T+3 follow-up. No October 19 company earnings release, attributable post-print price reaction, consensus comparison, analyst revision or target change was verified. The sentiment fields set to zero indicate unavailable measurements, not neutral readings. Maintain the prior cautious monitoring thesis despite the scheduled trigger and elevated thesis-change score.